CDH6-based diagnostic kit for Epstein-Barr virus-associated nasopharyngeal carcinoma
A diagnostic kit and EB virus technology, applied in the field of nasopharyngeal carcinoma diagnostic kits, can solve the problem of lack of research on CDH6, and achieve the effect of great popularization and application value and rapid auxiliary diagnosis.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Embodiment 1: RT-PCR diagnostic kit for Epstein-Barr virus-associated nasopharyngeal carcinoma of the present invention
[0029] The Epstein-Barr virus-associated nasopharyngeal carcinoma diagnostic kit of the present invention is a real-time quantitative PCR (real-time PCR / RT-PCR) kit, including CDH6-specific primers and internal reference β-actin-specific primers;
[0030] The CDH6-specific primer sequence is:
[0031] Forward: 5'-GTTGCCATCCTTCTGTGCAT-3'
[0032] Reverse: 5'-TTCCTCAGGGTGCCGATATC-3', respectively shown in SEQ ID No.1 and SEQ ID No.2;
[0033] The internal reference gene β-actin primer sequence is:
[0034] Forward: 5'-TCACCAACTGGGACGACATG-3'
[0035] Reverse: 5'-GTCACCGGAGTCCATCACGAT-3', respectively shown in SEQ ID No.3 and SEQ ID No.4;
[0036] The working concentration of the above-mentioned specific primers is 10 pM.
[0037] For more convenient use, this kit also includes an RNA extraction kit and a reverse transcription kit.
Embodiment 2
[0038] Example 2: Using the nasopharyngeal carcinoma diagnostic kit of the present invention to detect nasopharyngeal carcinoma patient tissues and normal human tissues and verify the results
[0039]Five normal human nasopharyngeal tissues and 35 nasopharyngeal carcinoma patient tissues were collected, total RNA was extracted, and real-time fluorescent quantitative PCR was performed after reverse transcription to analyze the differential expression of LMP1, miR-203 and CDH6. Finally, it was found that LMP1 was expressed in almost all tissues, and LMP1 was highly expressed in the tissues of 22 patients with nasopharyngeal carcinoma, compared with normal tissues, P≤0.001, the difference was significant, and the expression of miR-203 was down-regulated, P≤0.001 , the expression of its target gene CDH6 was up-regulated, P≤0.05. Similarly, in 13 NPC patients with low expression of LMP1, the expression of miR-203 was low, P ≤ 0.05, and the expression of target gene CDH6 was increas...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com